Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Safeguard Scientifics SFE -- Ignore unavailable to you. Want to Upgrade?

To: robert miller who wrote (1244)	3/17/1998 1:08:00 AM
From: michael r potter	Read Replies (1) \| Respond to of 4467

CCSC is trading at a $2.20 per share discount to its' conversion value based on the closing price for TLAB of $63 5/16. This discount will disappear upon completion of the proposed buyout (assuming that it goes through which appears likely). That puts an effective price of $45.58 on CCSC based on TLAB being $63 5/16. Good news for holders of CCSC and SFE as this would add another $.34 per share to SFE net asset value. Should TLAB break out above $65 with good volume it would be very favorable for TLAB/CCSC and SFE. Investors Business Daily recently highlighted the chart of CATP with favorable implications. Most other major partnership companies act well. Now if CMPC could just get unstuck... Mike